Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B–Deficient Mice
American Journal of Respiratory Cell and Molecular Biology · 2025
DOI: 10.1165/rcmb.2024-0247oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2025. Verfasst von Martin H Kang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Darby Children's Research Institute. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Genetic Therapy, Pulmonary Surfactant-Associated Protein B. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Pediatrics at the Medical University of South Carolina, NCI NIH HHS, Stem Cell Network.
Abstract (Originalsprache)
Surfactant protein-B (SP-B) deficiency is a lethal neonatal respiratory disease with few therapeutic options. Gene therapy using adeno-associated viruses (AAVs) to deliver human SFTPB cDNA (AAV-hSPB) can improve survival in a mouse model of SP-B deficiency. However, the effect of this gene therapy wanes. Gene therapy efficacy could be prolonged if AAV vectors could be redosed, but readministering vectors is hindered by an immune response that includes TLR9 (Toll-like receptor 9) recognition of unmethylated CpG DNA motifs in the AAV genome. One strategy to mitigate TLR9 recognition of AAV is to incorporate decoy nucleotide sequences within the AAV genome. In this work we examined if an AAV containing these TLR9 inhibitory oligonucleotide sequences (AAV-hSPBTLR9i) could mitigate the immune response sufficiently to redose AAV in the lungs and prolong the survival of SP-B–deficient mice. Indeed, AAV-hSPBTLR9i could be redosed multiple times, which significantly improved survival in our mouse model. This was partially a result of long-term increased SFTPB RNA and SP-B protein expression. Conversely, redosing AAV-hSPB resulted in the rapid death of SP-B–deficient mice after the second AAV dose. TLR9 inhibition enabled readministration by avoiding the broad stimulation of genes belonging to multiple pathways in the host immune and inflammatory responses, including components of the IFN pathways. Thus, redosing of AAV vectors in the lungs using TLR9 inhibitory sequences is a promising strategy for prolonging gene therapy efficacy, with a proof of concept for AAV readministration in a clinically relevant mouse model of SP-B deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Darby Children's Research Institute.
- Molecular and Cellular Biology and Pathobiology Program.
- Hollings Cancer Center, and.
- Department of Pathobiology, University of Guelph, Guelph, Ontario, Canada.
- Ottawa Hospital Research Institute.
- Wyss Institute for Biologically Inspired Engineering, and.
ORCID-Profile: Martin H Kang
Förderung
- Department of Pediatrics at the Medical University of South Carolina
- NCI NIH HHS
- Stem Cell Network
- American Society of Gene and Cell Therapy
- Institute of Circulatory and Respiratory Health
- Delaware-CTR ACCEL Program
- NIGMS NIH HHS
- Hollings Cancer Center at the Medical University of South Carolina
Zitieren
APA
Kang, M. H., Thomas, S. P., Westley, C., Blouin, T., Xu, L., Chan, Y. K., Lisk, E., Allen, S. E., Vadivel, A., Nangle, K., Ramamurthy, J., Pei, Y., Lewis, L. A., Chiang, J. J., Romeo, M. J., Vaena, S., O'Quinn, E. C., Schrecker, H. D., Langdon, C. G., …, & Thébaud, B. (2025). Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B–Deficient Mice. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2024-0247oc
Vancouver
Kang MH, Thomas SP, Westley C, Blouin T, Xu L, Chan YK, et al. Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B–Deficient Mice. American Journal of Respiratory Cell and Molecular Biology. 2025. doi:10.1165/rcmb.2024-0247oc
BibTeX
@article{Kang2025,
author = {Kang, Martin H and Thomas, Sylvia P and Westley, Caralyn and Blouin, Thomas and Xu, Liqun and Chan, Ying Kai and Lisk, Erin and Allen, Sarah E and Vadivel, Arul and Nangle, Kennedy and Ramamurthy, Janani and Pei, Yanlong and Lewis, Lunndon A and Chiang, Jessica J and Romeo, Martin J and Vaena, Silvia and O'Quinn, Elizabeth C and Schrecker, Henry D and Langdon, Casey G and Nietert, Paul J and Church, George M and Whitsett, Jeffrey A and Wootton, Sarah K and Thébaud, Bernard},
title = {Novel Immune Response Evasion Strategy to Redose Adeno-associated Viral Vectors and Prolong Survival in Surfactant Protein-B–Deficient Mice},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2025},
doi = {10.1165/rcmb.2024-0247oc}
}
EUVIMED